The role of fast neutron therapy in unresectable pelvic osteosarcoma: preliminary report
✍ Scribed by Carrie, C. ;Breteau, N. ;Negrier, S. ;Frappaz, D. ;Bouffet, E. ;Thiesse, P. H. ;Blay, J. Y. ;Clavel, M. ;Philip, T. ;Biron, P. ;Brunat-Mentigny, M.
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 278 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0098-1532
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Primary osteosarcoma of the pelvic bones represents less than 10% of all osteosarcoma. despite mutilating surgical procedures or high‐dose radiotherapy and neoadjuvant chemotherapy, local failures and distant metastases remain common. the 2‐year actuarial survival rate is less than 50% and the disease‐free survival is under 20% at 2 years. we report 4 cases of pelvic osteosarcoma treated by a combination of chemotherapy, photon beam and neutron beam radiotherapy. after a median follow‐up of 24 months, all 4 patients are alive and disease free. © 1994 wiley‐liss, inc.
📜 SIMILAR VOLUMES